Elexacaftor/Tezacaftor/Ivacaftor Improves Sinonasal Disease in Young Patients With Cystic Fibrosis: A Prospective Study
{{output}}
Objectives: Chronic rhinosinusitis is common among patients with cystic fibrosis (CF) and often significantly impacts their quality of life. The introduction of CFTR modulators, particularly the triple therapy of elexacaftor/teza... ...